Acro Biomedical Co., Ltd. (ACBM)

Acro Biomedical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0	0	0	0.01	0.1
Cash & Short-Term Investments	0	0	0	0.01	0.1
Cash Growth	760.92%	26.60%	-93.58%	-93.86%	425.56%
Receivables	-	-	-	0.64	0.6
Inventory	-	-	-	0.01	0.01
Prepaid Expenses	0.01	-	0	0	0
Other Current Assets	-	0	-	-	-
Total Current Assets	0.01	0.01	0	0.66	0.71
Property, Plant & Equipment	-	0.03	0.05	0.03	0.05
Other Long-Term Assets	-	-	0	0	0
Total Assets	0.01	0.03	0.06	0.69	0.76
Accounts Payable	0.06	0.15	0.15	0.08	0.03
Short-Term Debt	0.33	0.13	0.09	0.08	0.02
Current Portion of Leases	-	0.03	0.03	0.03	0.02
Current Unearned Revenue	0.02	0.02	0.02	0.02	0.02
Total Current Liabilities	0.4	0.33	0.29	0.2	0.09
Long-Term Leases	-	-	0.03	-	0.03
Total Liabilities	0.4	0.33	0.32	0.2	0.12
Common Stock	0.06	0.06	0.06	0.06	0.06
Additional Paid-In Capital	32.31	32.3	32.3	32.3	32.29
Retained Earnings	-32.76	-32.66	-32.62	-23.81	-7.94
Comprehensive Income & Other	-	-	-	-8.06	-23.77
Shareholders' Equity	-0.39	-0.29	-0.26	0.49	0.64
Total Liabilities & Equity	0.01	0.03	0.06	0.69	0.76
Total Debt	0.33	0.15	0.14	0.1	0.07
Net Cash (Debt)	-0.32	-0.15	-0.14	-0.1	0.02
Net Cash Per Share	-0.01	-0.00	-0.00	-0.00	0.00
Filing Date Shares Outstanding	60.04	60.04	60.04	60.04	60.04
Total Common Shares Outstanding	60.04	60.04	60.04	60.04	60.04
Working Capital	-0.39	-0.32	-0.29	0.46	0.61
Book Value Per Share	-0.01	-0.00	-0.00	0.01	0.01
Tangible Book Value	-0.39	-0.29	-0.26	0.49	0.64
Tangible Book Value Per Share	-0.01	-0.00	-0.00	0.01	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.